Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.
Cortes JE, Lin TL, Asubonteng K, Faderl S, Lancet JE, Prebet T. Cortes JE, et al. Among authors: asubonteng k. J Hematol Oncol. 2022 Oct 26;15(1):155. doi: 10.1186/s13045-022-01361-w. J Hematol Oncol. 2022. PMID: 36289532 Free PMC article. Clinical Trial.
Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy.
Sharma P, Sohn J, Shin SJ, Oh DY, Keam B, Lee HJ, Gizzi M, Kalinka E, de Vos FYFL, Ruscica D, Ferro S, Xiao F, Baverel P, Chen CC, Asubonteng K, Morsli N, Dirix L. Sharma P, et al. Among authors: asubonteng k. Clin Cancer Res. 2020 Jan 1;26(1):61-70. doi: 10.1158/1078-0432.CCR-19-1635. Epub 2019 Dec 4. Clin Cancer Res. 2020. PMID: 31801732 Clinical Trial.
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Zandberg DP, Algazi AP, Jimeno A, Good JS, Fayette J, Bouganim N, Ready NE, Clement PM, Even C, Jang RW, Wong S, Keilholz U, Gilbert J, Fenton M, Braña I, Henry S, Remenar E, Papai Z, Siu LL, Jarkowski A, Armstrong JM, Asubonteng K, Fan J, Melillo G, Mesía R. Zandberg DP, et al. Among authors: asubonteng k. Eur J Cancer. 2019 Jan;107:142-152. doi: 10.1016/j.ejca.2018.11.015. Epub 2018 Dec 18. Eur J Cancer. 2019. PMID: 30576970 Free article. Clinical Trial.
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study.
Mohty M, Blaise D, Peffault de Latour R, Labopin M, Bourhis JH, Bruno B, Ceballos P, Detrait M, Gandemer V, Huynh A, Izadifar-Legrand F, Jubert C, Labussière-Wallet H, Lebon D, Maury S, Paillard C, Pochon C, Renard C, Rialland F, Schneider P, Sirvent A, Asubonteng K, Guindeuil G, Yakoub-Agha I, Dalle JH. Mohty M, et al. Among authors: asubonteng k. Bone Marrow Transplant. 2023 Apr;58(4):367-376. doi: 10.1038/s41409-022-01900-6. Epub 2022 Dec 23. Bone Marrow Transplant. 2023. PMID: 36564486 Free PMC article.
COVID-19, poverty and inclusive development.
Gupta J, Bavinck M, Ros-Tonen M, Asubonteng K, Bosch H, van Ewijk E, Hordijk M, Van Leynseele Y, Lopes Cardozo M, Miedema E, Pouw N, Rammelt C, Scholtens J, Vegelin C, Verrest H. Gupta J, et al. Among authors: asubonteng k. World Dev. 2021 Sep;145:105527. doi: 10.1016/j.worlddev.2021.105527. Epub 2021 Apr 27. World Dev. 2021. PMID: 36570384 Free PMC article.